Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Szeremeta

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|November 13, 2025
Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot StudyAleksandra Górecka, Agnieszka Jura-Półtorak, Anna Szeremeta, et al.
Journal of Clinical Medicine|July 27, 2022
TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid ArthritisAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor TherapyAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Journal of Clinical Medicine|July 2, 2021
Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α InhibitorsAgnieszka Jura-Półtorak, Anna Szeremeta, Krystyna Olczyk, et al.
Journal of Clinical Medicine|August 26, 2023
Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid ArthritisAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Molecules (Basel, Switzerland)|October 16, 2024
Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease ProgressionAleksandra Górecka, Agnieszka Jura-Półtorak, Ewa M Koźma, et al.
Journal of Clinical Medicine|May 13, 2020
Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α InhibitorsAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Arthritis Research & Therapy|September 20, 2018
Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritisAnna Szeremeta, Agnieszka Jura-Półtorak, Ewa Maria Koźma, et al.
Clinical Biochemistry|June 24, 2014
Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent populationKatarzyna Komosinska-Vassev, Dorota Blat, Paweł Olczyk, et al.
Journal of Clinical Medicine|February 26, 2025
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with MetforminAnna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|November 13, 2025
Diagnostic Potential of Periostin, Galectin-3 and Tenascin C Serum Measurements in Inflammatory Bowel Disease: Pilot StudyAleksandra Górecka, Agnieszka Jura-Półtorak, Anna Szeremeta, et al.
Journal of Clinical Medicine|July 27, 2022
TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid ArthritisAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor TherapyAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Journal of Clinical Medicine|July 2, 2021
Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α InhibitorsAgnieszka Jura-Półtorak, Anna Szeremeta, Krystyna Olczyk, et al.
Journal of Clinical Medicine|August 26, 2023
Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid ArthritisAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Molecules (Basel, Switzerland)|October 16, 2024
Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease ProgressionAleksandra Górecka, Agnieszka Jura-Półtorak, Ewa M Koźma, et al.
Journal of Clinical Medicine|May 13, 2020
Aggrecan Turnover in Women with Rheumatoid Arthritis Treated with TNF-α InhibitorsAnna Szeremeta, Agnieszka Jura-Półtorak, Aleksandra Zoń-Giebel, et al.
Arthritis Research & Therapy|September 20, 2018
Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritisAnna Szeremeta, Agnieszka Jura-Półtorak, Ewa Maria Koźma, et al.
Clinical Biochemistry|June 24, 2014
Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent populationKatarzyna Komosinska-Vassev, Dorota Blat, Paweł Olczyk, et al.
Journal of Clinical Medicine|February 26, 2025
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with MetforminAnna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Pageof 1